Exit Interview: FDA's Joshua Sharfstein Reflects On Brief But Busy Tenure
This article was originally published in The Gray Sheet
FDA Principal Deputy Commissioner Joshua Sharfstein relinquished his post Jan. 7 to become secretary of the Maryland Department of Health and Mental Hygiene.
You may also be interested in...
People Briefs: HeartWare CMO, New Posts For Former HHS Officials
HeartWare International names Katrin Leadley chief medical officer. Former CMS Deputy Administrator Jonathan Blum to join CareFirst Blue Cross, while former FDA Deputy Commissioner Sharfstein joins Johns Hopkins. Propeller Health taps senior VP for business and client development.
Incoming FDA Medical Products Official Has Strong Industry Ties
Former J&J executive Leona Brenner-Gati will become acting deputy commissioner for medical products and tobacco following the departure of Stephen Spielberg.
FDA Counselor Taylor Named Acting Deputy As Hamburg Mulls Reorganization
John Taylor, counselor to FDA Commissioner Margaret Hamburg, will fill the role vacated by Principal Deputy Commissioner Joshua Sharfstein on an acting basis for 60 days and could be well positioned to ultimately take over the job permanently.